- Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group2018 | 1. lékařská fakulta
- Souvislosti mezi léčbou canagliflozinem a rizikem amputací v programu CANVAS2020 | 2. lékařská fakulta
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes2017 | 2. lékařská fakulta